How To Measure ROI in Decentralized Clinical Trials
At the 2024 DPHARM conference, Ken Getz, Executive Director and Research Professor at Tufts Center for the Study of...
Moe Alsumidaie
Navigating Clinical Research Technology As a Study Site
In this interview, we sit down with Alisha Garibaldi, CEO of Skylight Health Research, to discuss managing clinical research...
How Geopolitical Economic Changes Are Impacting Big Pharma
Globalization has long been seen as a cornerstone of growth for the big pharma industry, enabling companies to expand...
How AI is Transforming RBQM in Clinical Trials
A recent virtual summit hosted by Cyntegrity focused on the pivotal role of artificial intelligence (AI) in Risk-Based Quality...
Innovating Biothreat Therapies: An Interview with Head of GigaGen
In this interview, Carter Keller, Head of GigaGen and SVP at Grifols, discusses the company’s groundbreaking work in developing...
Johnson & Johnson’s Innovative Approach to Enhancing Diversity in Clinical Trials
At DPHARM 2024, Johnson & Johnson (J&J) unveiled their groundbreaking strategies to improve diversity, equity, and inclusion (DE&I) in...
Navigating Complexities in Obesity Clinical Trials: Insights from Skye Bioscience
In this interview, we met with Dr. Puneet Arora, Chief Medical Officer at Skye Bioscience, to explore the intricacies...
How To Leverage eClinical Technology to Enhance Sponsor-Site Collaboration
In this insightful discussion, we interview Kenny Kong, Vice President of Strategy for Veeva Site Connect. He delves into...
How to Navigate Rare Disease Clinical Trial Recruitment
In this discussion, we interview Sara Riordan, VP of Strategy at Genome Medical, on the complexities of recruiting for...
Navigating the Future of Clinical Trials: Insights from PicnicHealth Chief Medical Officer
In this interview, we speak with Dan Drozd, Chief Medical Officer at PicnicHealth, about the challenges and innovations in...